Haruhiko Koseki

Crest
Kawaguchi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 247 publications

Satb1 enforces CD4+ effector T cell lineage stability by repressing Foxp3 via DNA methylation.

Satb1 enforces CD4+ effector T cell lineage stability by repressing Foxp3 via DNA methylation.

Journal: Biochemical and biophysical research communications

Published: May 15, 2026

Extending the residence period of allogeneic iPSC-derived invariant natural killer T cells in humanized mice by editing HLA class I expression.

Extending the residence period of allogeneic iPSC-derived invariant natural killer T cells in humanized mice by editing HLA class I expression.

Journal: Frontiers in cell and developmental biology

Published: April 30, 2026

The hard truth about how hard it is to publish in Development.

The hard truth about how hard it is to publish in Development.

Journal: Development (Cambridge, England)

Published: January 02, 2026

Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome.

Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome.

Journal: Blood

Published: October 16, 2025

Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome.

Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome.

Journal: Blood

Published: October 16, 2025

Interleukin-22 and Interleukin-18 as Potential Blood Biomarkers in Dupilumab-Treated Atopic Dermatitis.

Interleukin-22 and Interleukin-18 as Potential Blood Biomarkers in Dupilumab-Treated Atopic Dermatitis.

Journal: Allergy

Published: October 14, 2025

TMPRSS2-induced Golgi disruption restricts the incorporation of virus envelope glycoproteins into virions.

TMPRSS2-induced Golgi disruption restricts the incorporation of virus envelope glycoproteins into virions.

Journal: EMBO reports

Published: September 29, 2025

A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol.

A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol.

Journal: PloS one

Published: September 19, 2025

Usp21 Knockout Causes Abnormal Lipid Metabolism in Mouse and Its Polymorphism Correlates with Hypercholesterolemia in Outpatients.

Usp21 Knockout Causes Abnormal Lipid Metabolism in Mouse and Its Polymorphism Correlates with Hypercholesterolemia in Outpatients.

Journal: International journal of molecular sciences

Published: August 09, 2025

Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed antigen-presenting cells.

Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed antigen-presenting cells.

Journal: Stem cell research & therapy

Published: July 12, 2025

Membrane topology inversion of GGCX mediates cytoplasmic carboxylation for antiviral defense.

Membrane topology inversion of GGCX mediates cytoplasmic carboxylation for antiviral defense.

Journal: Science (New York, N.Y.)

Published: July 03, 2025

Allogeneic iPSC-derived iNKT cells in recurrent head and neck cancer: a phase 1 trial.

Allogeneic iPSC-derived iNKT cells in recurrent head and neck cancer: a phase 1 trial.

Journal: Nature communications

Published: July 01, 2025

Showing 1-12 of 247

Last Updated: 09/26/2026